<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83024">
  <stage>Registered</stage>
  <submitdate>30/07/2008</submitdate>
  <approvaldate>30/09/2008</approvaldate>
  <actrnumber>ACTRN12608000497303</actrnumber>
  <trial_identification>
    <studytitle>Steroids prevent nausea and vomiting after open gynaecological surgery, but do they harm the immune system?</studytitle>
    <scientifictitle>The influence of antiemetic doses of dexamethasone on postoperative lymphocyte sub-populations after open gynaecological surgery</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Postoperative immune function</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Dexamethasone 4 mg or 8 mg (as determined by randomisation sequence)given intravenously once at induction of anaesthesia</interventions>
    <comparator>Active control (Droperidol 625 mcg) given intravenously once at the induction of anaesthesia. Single dose only</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>An alteration in T- and B-lymphocyte sub-populations as measured by blood sample analysis</outcome>
      <timepoint>Preoperative; 24 hours postoperatively, 48 hours postoperatively, 72 hours postoperatively, 96 hours postoperatively, and one blood test taken between 4 and 6 weeks postoperatively</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>None</outcome>
      <timepoint>None</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Females undergoing open gynaecologic surgery
American Society of Anesthesiologists (ASA) classification 1-3 patients</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Current drug therapy with antiemetic or systemic steroidal activity
Known or suspected metastatic disease
Recent treatment with chemotherapeutic agents
Patients involving implants, such as mesh repairs
Opioid-tolerance
Hypertension
Diabetes mellitus
Peptic ulceration
Intolerance to non-steroidal anti-inflammatory drugs
Hypersensitivity to dexamethasone, granisetron or droperidol</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocations will be concealed in sealed opaque envelopes</concealment>
    <sequence>Computer-generated random number sequence</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/09/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>75</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Professor Michael Paech</primarysponsorname>
    <primarysponsoraddress>Dept of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot Road
Subiaco, WA 6008</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Perth Hospital</fundingname>
      <fundingaddress>Department of Anaesthesia
Royal Perth Hospital
GPO Box Z2213
Perth, WA 6001</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Neil Muchatuta</sponsorname>
      <sponsoraddress>Dept of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot Road
Subiaco, WA 6008</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Dr Tomas Corcoran</othercollaboratorname>
      <othercollaboratoraddress>Dept of Anaesthesia
Royal Perth Hospital
GPO Box Z2213
Perth, WA 6001</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Postoperative nausea and vomiting remains a significant problem in modern anaesthetic practice. One of the most effective anti-sickness agents (antiemetics) available is a steroid drug: dexamethasone. Steroids are also used to supress the immune system and inflammation in the body. This immune supression can also predispose to the development of infection. We wish to investigate whether the small doses of dexamethasone used in anaesthesia affects the nature and function of important immune system cells known as lymphocytes.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>9/06/2008</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Tomas Corcoran</name>
      <address>Dept of Anaesthesia
Royal Perth Hospital
GPO Box Z2213
Perth, WA 6001</address>
      <phone>08 9224 1038</phone>
      <fax>08 9224 1111</fax>
      <email>tomas.corcoran@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Michael Paech, Research Fellow, or Research Nurses</name>
      <address>Dept of Anaesthesia and Pain Medicine
King Edward Memorial Hospital for Women
374 Bagot Road
Subiaco, WA 6008</address>
      <phone>09 9340 2222 pager 3223 (Prof Paech), 3226 (Reasearch Fellow), or 3433 (Research Nurses)</phone>
      <fax>08 9340 2260</fax>
      <email>michael.paech@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>